Abstract:BackgroundThere are five different anti-TNF biologics: three are bivalent full length (FL) antibodies (adalimumab, golimumab, and infliximab), one a bivalent fusion protein (etanercept), and one a univalent PEGylated Fab' (PF) (certolizumab pegol [CZP]). Administration of such protein biologics can induce anti-drug antibodies (ADAbs), of which the majority are anti-idiotypic antibodies (anti-ID).1 The potential cross-linking of bivalent anti-IDs with bivalent biologics can result in the formation of large immu… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.